Cytiva and Fida Biosystems Combine Technologies to Expand Protein Analysis

Cytiva and Fida Biosystems, a Danish company specializing in molecular analysis, agreed to collaborate to expand analytical capabilities for protein research. The agreement combines Cytiva’s Biacore surface plasmon resonance (SPR) systems with Fidabio’s in-solution flow-induced dispersion analysis (FIDA) technology.

The tech collaboration provides both a complementary and an orthogonal approach that gives scientists a more complete picture of molecular interactions, according to Cytiva. By linking structural details—such as protein size and stability—with binding and interaction data, researchers can make faster, more confident decisions earlier in development, explains Tim Bervoets, president, discovery and medical, Cytiva.

“Combining technologies with Cytiva fosters deeper insight, giving researchers greater confidence in their results,” notes Brian Sørensen, CEO, Fida Biosystems. “This collaboration supports our mission to advance biophysical analysis and empower scientists with faster, more informative data for complex molecular research.”

“Researchers need to understand how their molecules behave, and they need that insight quickly,” adds Bervoets. “Pairing Biacore SPR with FIDA measurements gives them a more complete picture, without adding complexity. It’s a practical step forward that supports confident decisions and keeps workflows moving. In essence, it helps accelerate the researcher’s time to insight.”

The post Cytiva and Fida Biosystems Combine Technologies to Expand Protein Analysis appeared first on GEN - Genetic Engineering and Biotechnology News.